感染症診断薬市場レポート：2022-2032

Infectious Disease Diagnostics Market Report 2022-2032

レポート詳細感染症診断薬市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものと... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年12月16日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	325	321	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

感染症診断薬市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

感染症患者数の増加、集中型ラボから分散型POC検査へのシフトが市場成長を牽引
感染症の有病率の高まりは、予測期間中の感染症診断市場の成長を促進すると予想されます。例えば、2020年2月23日、中国本土で76,936件、中国本土以外の場所で1,875件のコロナウイルス疾患2019が報告され、関連する死亡者数は2,462人となっています。

国連合同エイズ計画（UNAIDS）によると、2020年のHIV陽性者は3770万人で、そのうち3600万人が成人、170万人が0～14歳の子どもです。さらに、半数以上（53％）が女性でした。2020年には世界で150万人の新規HIV感染者が記録されています。さらに、肝炎は、肝臓に炎症を起こすウイルス感染症です。肝炎ウイルスには、主に5つの系統があります。世界保健機関（WHO）によると、世界で約5800万人がC型慢性肝炎ウイルスに感染しており、毎年150万人が新たに感染しています。

WHOによると、COVID-19に続き、結核は世界で2番目に多い感染症であり、全体の死因としては13番目に多いものです。WHOによると、2020年には結核が原因で150万人が死亡（HIV感染者21万4,000人を含む）しています。WHOは、2020年に世界で110万人の子ども、330万人の女性、560万人の男性を含む1,000万人が結核の影響を受けると予想しています。すべての国、すべての年齢層が結核の影響を受けています。さらに、結核の負担が重い30カ国が、2020年の結核新規患者の86％を占めています。その3分の2は、インドを筆頭に、中国、フィリピン、ナイジェリア、パキスタン、インドネシア、バングラデシュ、南アフリカの8カ国で占められています。

さらに、世界的に医療関連感染症（HAI）の蔓延が進んでいます。例えば、米国疾病管理センター（CDC）によると、米国の病院におけるHAIだけでも、年間170万件の感染と9万9000件の関連死があると考えられています。これらの感染症のうち、尿路感染症は医療関連感染症全体の32%を占め、次いで手術部位感染症（22%）、肺炎（15%）、血流感染症（14%）の順となっています。

先進国や新興国における感染症の流行は、感染症診断薬市場の成長にプラスの影響を与えると考えられます。感染症の診断と管理は、感染症診断の処方件数を増加させる重要な要因となっています。COVID-19の予防および管理対策には、大規模な集団ベースの診断検査が必要です。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 感染症診断薬市場はどのように進化しているのか？
- 感染症診断薬市場の推進要因と抑制要因は何か？
- 感染症診断薬サブマーケットの各セグメントは予測期間中にどのように成長し、2032年にはどの程度の売上を占めるようになるのか？
- 2022年から2032年にかけて、各感染症診断薬サブマーケットの市場シェアはどのように推移するのか？
- 2022年から2032年にかけて、市場全体の主なドライバーは何になるのか？
- 感染症診断薬の主要市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国別市場が他を凌駕するのか？
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、また予測期間中の見通しは？
- これらのリーディング企業の感染症診断薬研究プロジェクトは何か？
- 2022年から2032年の間に、業界はどのように進化するのか？現在および今後10年間に実施される感染症診断薬プロジェクトはどのような意味を持つのか？
- 感染症診断薬市場をさらに拡大するために、製品の商業化の必要性は高いか？
- 感染症診断薬市場の方向性と、市場の最前線に立つためにはどうすればよいか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の感染症診断薬市場にどのような影響を与えるかを知る必要があります。

- Visiongainの32ページにわたるレポートでは、120の表と201のチャート/グラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットにすることができます。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、感染症診断薬市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と回復の変動に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要です。

2032年までの予測やその他の分析により、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場ダイナミクス、ドライバー、機会、阻害要因、課題など）、コスト構造、感染症診断薬価格高騰の影響、最近の動向などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を及ぼすかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

製品
- 装置
- 試薬・キット・消耗品
- ソフトウェアとサービス

検査タイプ
- ラボ試験
- POC検査

技術紹介
・免疫診断薬
・ポリメラーゼ連鎖反応(PCR)
- リアルタイムPCR/qPCR
- 逆転写酵素PCR(RT-PCR)
- マルチプレックスPCR
- その他
・ DNAシーケンスおよび次世代シーケンス(NGS)
・臨床微生物学
・その他の技術

用途
- COVID-19
- ヒト免疫不全ウイルス(HIV)
- 医療関連感染（HAI)
- 肝炎
- ヒトパピローマウイルス(HPV)
- 結核（TB）
- インフルエンザ
- その他の感染症

用途
- 診断研究所
- 病院・診療所
- 研究機関
- 在宅医療現場
- その他エンドユーザー

世界市場全体とセグメントの収益予測に加え、5つの地域と19の主要国市場の収益予測も掲載しています。

北米
- 米国
- カナダ

欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- ラテンアメリカ地域

MEA
- GCC
- 南アフリカ
- その他のMEA地域

感染症診断薬市場の主要企業のプロファイルと2022年から2032年まで、これらの企業のこのセグメントに焦点を当てた情報も掲載しています。

主要企業と市場成長の可能性
・ Abbott
・ Alere Inc.
・ BioMérieux SA
・ Becton, Dickinson and Company
・ Cepheid, Inc.
・ Co-Diagnostics
・ Chembio Diagnostic Systems
・ Danaher Corporation
・ DiaSorin S.p.A.
・ ELITechGroup
・ Epitope Diagnostics
・ F. Hoffmann-La Roche
・ Hologic, Inc.
・ Grifols S.A.
・ Genetic Signatures Ltd.
・ InBios International
・ Meridian Bioscience
・ Ortho Clinical Diagnostics Holdings plc
・ OraSure Technologies
・ PerkinElmer Inc.
・ Siemens Healthineers
・ Sysmex Corporation
・ Thermo Fisher Scientific
・ Trinity Biotech Plc.
・ Trivitron Healthcare
・ Uniogen Oy
・ Vela Diagnostics
・ Meril Life Sciences Pvt. Ltd
・ Quidel Corporation.

感染症診断薬市場の世界全体の収益、2022年から2032年まで、金額ベースで2022年に299億4030万米ドルを突破すると、我々の仕事は計算しています。また、2032年までの間に売上高が大きく伸びると予測しています。本調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

感染症診断薬市場、2022年から2032年までのレポートはどのように役立つのでしょうか？
320ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 感染症診断市場の2032年までの収益予測、タイプ別、企業規模別に世界と地域レベルでそれぞれ予測 - 投資と収益に最も有利な場所を見つけ、業界の展望を発見する。

- 5つの地域と19の主要国市場の2032年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの感染症診断薬市場、2022年から2032年の市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 既存企業および市場参入を目指す企業の展望 - 感染症診断薬市場に関わる主要企業10社の企業プロファイルを含む、2022年から2032年までの展望。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、感染症診断市場、2022年から2032年、市場の主要企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1.レポートの概要
1.1 調査の目的
1.2 感染症診断薬市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが答える重要な質問
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場の推進要因
3.2.1.1 感染症の普及率の増加
3.2.1.2 集中型ラボから分散型POC検査へのシフト
3.2.1.3 民間・政府組織による診断サービスセンターへの資金提供の増加
3.2.2 市場阻害要因
3.2.2.1 不利な保険償還シナリオ
3.2.2.2 スキルアップのための専門家不足
3.2.3 市場機会
3.2.3.1 成長する経済圏での機会拡大
3.2.3.2 費用対効果が高く、信頼性の高い検査キットの導入
3.3 COVID-19影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 供給者のバーゲニングパワー
3.4.2 バイヤーのバーゲニングパワー
3.4.3 競争相手との競合
3.4.4 代替品による脅威
3.4.5 新規参入者の脅威
3.5 PEST分析

4 感染症診断薬市場分析：製品別
4.1 主な調査結果
4.2 製品セグメント別の成長展望
4.3 感染症診断薬の製品別市場規模の推定と予測
4.4 計測機器
4.4.1 地域別市場規模、2022年～2032年 (US$ Million)
4.4.2 地域別市場シェア、2022年＆2032年(%)
4.5 試薬、キット、消耗品
4.5.1 地域別市場規模、2022年～2032年(US$ Million)
4.5.2 地域別市場シェア、2022年＆2032年(%)
4.6 ソフトウェア＆サービス
4.6.1 地域別市場規模、2022年～2032年(US$ Million)
4.6.2 地域別市場シェア、2022年＆2032年(%)

5 感染症診断薬市場分析：検査タイプ別
5.1 主な調査結果
5.2 検査の種類別セグメントの成長展望
5.3 感染症診断薬の検査タイプ別市場規模の推定と予測
5.4 ラボ検査
5.4.1 地域別市場規模、2022年～2032年(US$ Million)
5.4.2 地域別市場シェア、2022年＆2032年(%)
5.5 POC検査
5.5.1 地域別市場規模、2022年〜2032年(US$ Million)
5.5.2 地域別市場シェア、2022年＆2032年(%)

6 感染症診断薬市場分析：技術別
6.1 主な調査結果
6.2 技術セグメントの成長展望
6.3 感染症診断薬の技術別市場規模の推定と予測
6.4 免疫診断薬
6.4.1 地域別市場規模、2022年～2032年(US$ Million)
6.4.2 地域別市場シェア、2022年＆2032年(%)
6.6 ポリメラーゼ連鎖反応(PCR)
6.6.1 地域別市場規模、2022年～2032年 (US$ Million)
6.6.2 地域別市場シェア、2022年＆2032年(%)
6.7 DNAシーケンサーと次世代シーケンサー（NGS）
6.7.1 地域別市場規模、2022年～2032年 (US$ Million)
6.7.2 地域別市場シェア、2022年＆2032年(%)
6.8 臨床微生物学
6.8.1 地域別市場規模、2022年～2032年(US$ Million)
6.8.2 地域別市場シェア、2022年＆2032年(%)
6.9 その他の技術
6.9.1 地域別市場規模、2022年～2032年(US$ Million)
6.9.2 地域別市場シェア、2022年＆2032年(%)

7 感染症診断薬市場分析：用途別
7.1 主な調査結果
7.2 アプリケーション別成長展望
7.3 感染症診断薬のアプリケーション別市場規模の推定と予測
7.4 COVID-19
7.4.1 地域別市場規模、2022年～2032年(US$ Million)
7.4.2 地域別市場シェア、2022年＆2032年(%)
7.5 ヒト免疫不全ウイルス(HIV)
7.5.1 地域別市場規模、2022年～2032年(US$ Million)
7.5.2 地域別市場シェア、2022年＆2032年(%)
7.6 医療関連感染（HAI)
7.6.2 地域別市場シェア、2022年＆2032年(%)
7.7 肝炎
7.7.1 地域別市場規模、2022年＆2032年(US$ Million)
7.7.2 地域別市場シェア、2022年＆2032年(%)
7.8 ヒトパピローマウイルス(HPV)
7.8.2 地域別市場シェア、2022年＆2032年(%)
7.9 結核(TB)
7.9.1 地域別市場規模、2022年＆2032年 (US$ Million)
7.9.2 地域別市場シェア、2022年＆2032年(%)
7.10 インフルエンザ（Influenza
7.10.1 地域別市場規模、2022年〜2032年(US$ Million)
7.10.2 地域別市場シェア、2022年＆2032年(%)
7.11 その他の感染症
7.11.1 地域別市場規模、2022年〜2032年 (US$ Million)
7.11.2 地域別市場シェア、2022年＆2032年(%)

8 感染症診断薬市場分析：エンドユーザー別
8.1 主な調査結果
8.2 エンドユーザーセグメントの成長展望
8.3 感染症診断薬のエンドユーザー別市場規模の推定と予測
8.4 診断ラボラトリー
8.4.2 地域別市場シェア、2022年＆2032年(%)
8.5 病院・診療所
8.5.1 地域別市場規模、2022年～2032年(US$ Million)
8.5.2 地域別市場シェア、2022年＆2032年(%)
8.6 研究機関
8.6.1 地域別市場規模、2022年～2032年(US$ Million)
8.6.2 地域別市場シェア、2022年＆2032年(%)
8.7 在宅介護の現場
8.7.1 地域別市場規模、2022年～2032年(US$ Million)
8.7.2 地域別市場シェア、2022年＆2032年(%)
8.8 その他のエンドユーザー
8.8.1 地域別市場規模、2022年～2032年 (US$ Million)
8.8.2 地域別市場シェア、2022年＆2032年(%)

9 感染症診断薬市場分析：地域別
9.1 主要な調査結果
9.2 地域別市場規模の推定と予測
9.3 COVID-19の影響度分析。回復シナリオ(V, U, W, L)

10 北米の感染症診断薬市場分析
10.1 主な調査結果
10.2 北米感染症診断薬市場の魅力度指数
10.3 北米感染症診断薬国別市場2022年、2027年＆2032年(US$ Million)
10.4 北米感染症診断薬国別市場規模予測・予想
10.5 北米感染症診断薬市場の製品別市場規模予測・予測
10.6 北米感染症診断薬市場の検査タイプ別市場規模予測・予想
10.7 北米感染症診断薬市場の技術別市場規模予測・予測
10.8 北米感染症診断薬市場の用途別市場規模予測・予測
10.9 北米感染症診断薬市場のエンドユーザー別市場規模予測・予想
10.10 米国の感染症診断薬市場分析
10.11 カナダの感染症診断薬の市場分析

11 欧州の感染症診断薬市場分析
11.1 主な調査結果
11.2 欧州感染症診断薬市場の魅力度指数
11.3 欧州感染症診断薬国別市場 2022年、2027年＆2032年(US$ Million)
11.4 欧州感染症診断薬国別市場規模予測・予測
11.5 欧州感染症診断薬市場製品別市場規模予測・予測
11.6 欧州感染症診断薬市場の検査タイプ別市場規模予測・予測
11.7 欧州感染症診断薬市場の技術別市場規模予測・予測
11.8 欧州感染症診断薬市場規模予測・用途別予測
11.9 欧州感染症診断薬市場のエンドユーザー別市場規模予測・予測
11.10 ドイツの感染症診断薬の市場分析
11.11 イギリスの感染症診断薬市場の分析
11.12 フランスの感染症診断薬市場の分析
11.12 イタリア感染症診断薬市場の分析
11.13 スペイン感染症診断薬市場の分析
11.14 ロシア感染症診断薬市場の分析
11.15 その他の欧州感染症診断薬市場の分析

12 アジア太平洋地域の感染症診断薬市場分析
12.1 主な調査結果
12.2 アジア太平洋地域の感染症診断薬市場の魅力度指数
12.3 アジア太平洋地域の感染症診断薬市場の国別推移、2022年、2027年、2032年(US$ Million)
12.4 アジア太平洋地域の感染症診断薬の国別市場規模予測・予想
12.5 アジア太平洋地域の感染症診断薬市場の製品別市場規模予測・予測
12.6 アジア太平洋地域の感染症診断薬市場の検査タイプ別市場規模予測・予測
12.7 アジア太平洋地域の感染症診断薬の市場規模予測・技術別予測
12.8 アジア太平洋地域の感染症診断薬市場の用途別市場規模予測・予測
12.9 アジア太平洋地域の感染症診断薬市場のエンドユーザー別市場規模予測・予想
12.10 日本感染症診断薬市場分析
12.11 中国感染症診断薬市場の分析
12.12 インドの感染症診断薬市場の分析
12.13 オーストラリアの感染症診断薬の市場分析
12.14 韓国感染症診断薬市場の分析
12.15 その他のアジア太平洋地域の感染症診断薬の市場分析

13 ラテンアメリカの感染症診断薬市場分析
13.1 主な調査結果
13.2 ラテンアメリカの感染症診断薬市場の魅力度指数
13.3 ラテンアメリカの感染症診断薬市場の国別推移、2022年、2027年、2032年 (US$ Million)
13.4 ラテンアメリカの感染症診断薬の国別市場規模予測・予想
13.5 ラテンアメリカの感染症診断薬市場の製品別市場規模予測・予測
13.6 ラテンアメリカの感染症診断薬市場の検査タイプ別市場規模予測・予想
13.7 ラテンアメリカの感染症診断薬市場の技術別市場規模予測・予測
13.8 ラテンアメリカの感染症診断薬市場の用途別市場規模予測・予測
13.9 ラテンアメリカの感染症診断薬市場のエンドユーザー別市場規模予測・予想
13.10 ブラジル感染症診断薬市場分析
13.11 メキシコの感染症診断薬市場の分析
13.12 その他のラテンアメリカの感染症診断薬市場分析

14 MEAの感染症診断薬市場分析
14.1 主な調査結果
14.2 MEA感染症診断薬市場の魅力度指数
14.3 MEA感染症診断薬市場の国別推移、2022年、2027年＆2032年 (US$ Million)
14.4 MEA感染症診断薬の国別市場規模予測・予想
14.5 MEA感染症診断薬市場の製品別市場規模予測・予測
14.6 MEAの感染症診断薬市場の検査タイプ別市場規模予測・予想
14.7 MEA感染症診断薬市場の技術別市場規模予測・予測
14.8 MEA感染症診断薬市場の用途別市場規模予測・予測
14.9 MEA感染症診断薬市場のエンドユーザー別市場規模予測・予想
14.10 GCCの感染症診断薬の市場分析
14.11 南アフリカの感染症診断薬市場の分析
14.12 その他のMEA感染症診断薬市場の分析

15 主要企業のプロフィール
15.1 競合他社の状況、2021年
15.2 Danaher Corporation
15.2.1 企業スナップショット
15.2.2 会社概要
15.2.3 財務分析
15.2.3.1 純収益、2017-2021年
15.2.3.2 R＆D、2017年～2021年
15.2.3.3 地域別市場シェア、2021年
15.2.4 製品ベンチマーク
15.2.5 戦略的な展望
15.3 PerkinElmer Inc.
15.3.1 企業スナップショット
15.3.2 会社概要
15.3.3 財務分析
15.3.3.1 純収益、2017-2021年
15.3.3.2 R＆D、2017年～2021年
15.3.3.3 地域別市場シェア、2021年
15.3.4 製品ベンチマーク
15.3.5 戦略的な展望
15.4 Abbott
15.4.1 企業スナップショット
15.4.2 会社概要
15.4.3 財務分析
15.4.3.1 純収益、2017-2021年
15.4.3.2 R＆D、2017年-2021年
15.4.3.3 地域別市場シェア、2021年
15.4.4 製品ベンチマーク
15.4.5 戦略的な展望
15.5 BioMérieux SA
15.5.1 企業スナップショット
15.5.2 会社概要
15.5.3 財務分析
15.5.3.1 純収益、2017-2021年
15.5.3.2 R＆D、2017年-2021年
15.5.3.3 地域別市場シェア、2021年
15.5.4 製品ベンチマーク
15.5.5 戦略的な展望
15.6 F. Hoffmann-La Roche Ltd
15.6.1 企業スナップショット
15.6.2 会社概要
15.6.3 財務分析
15.6.3.1 純収益、2017-2021年
15.6.3.2 R＆D、2017年-2021年
15.6.3.3 地域別市場シェア、2021年
15.6.4 製品ベンチマーク
15.6.5 戦略的な展望
15.7 Becton, Dickinson and Company
15.7.1 企業スナップショット
15.7.2 会社概要
15.7.3 財務分析
15.7.3.1 純収益、2017-2021年
15.7.3.2 R＆D、2017年-2021年
15.7.3.3 地域別市場シェア、2021年
15.7.4 製品ベンチマーク
15.7.5 戦略的な展望
15.8 Bio-Rad Laboratories
15.8.1 企業スナップショット
15.8.2 会社概要
15.8.3 財務分析
15.8.3.1 純収益、2017-2021年
15.8.3.2 R＆D、2017年-2021年
15.8.3.3 地域別市場シェア、2021年
15.8.4 製品ベンチマーク
15.8.5 戦略的展望
15.9 Siemens Healthineers
15.9.1 企業スナップショット
15.9.3 財務分析
15.9.3.1 純収益、2017-2021年
15.9.3.2 R＆D、2017年-2021年
15.9.3.3 地域別市場シェア、2021年
15.9.4 製品ベンチマーク
15.9.4 戦略的な展望
15.10 Thermo Fisher Scientific
15.10.1 企業スナップショット
15.10.2 会社概要
15.10.3 財務分析
15.10.3.1 純収益、2017-2021年
15.10.3.2 R＆D、2017年-2021年
15.10.3.3 地域別市場シェア、2021年
15.10.4 製品ベンチマーク
15.10.5 戦略的な展望
15.11 Quidel Corporation
15.11.1 企業スナップショット
15.11.2 会社概要
15.11.3 財務分析
15.11.3.1 純収益、2017-2021年
15.11.3.2 R＆D、2017年-2021年
15.11.3.3 地域別市場シェア、2021年
15.11.4 製品ベンチマーク
15.11.5 戦略的展望

16 結論と提言
16.1 ヴィジョンゲインからの結論
16.2 市場関係者への提言

表の一覧
Table 1 Infectious Disease Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 3 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 7 Instrument Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 9 Software & Services Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 10 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 11 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 12 POC Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 14 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 15 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 16 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 17 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 18 Immunodiagnostics market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 20 COVID-19 Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 21 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 23 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 24 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 25 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 26 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 27 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 28 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 29 Global Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 30 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 31 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 32 Research Institutes Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 33 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 34 Other End Users Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 35 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%))
Table 36 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 37 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 38 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 39 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 40 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 41 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 42 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 43 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 44 North America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 45 North America Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 46 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 47 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 48 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 49 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 50 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 51 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 52 Europe Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 53 Europe Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 54 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 55 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 56 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 57 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 58 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 59 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 60 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 61 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 62 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 63 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 64 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 65 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 66 Asia Pacific Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 67 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 68 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 69 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 70 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 71 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 73 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 74 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 75 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 76 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 77 Latin America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 78 Latin America Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 79 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 80 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 81 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 82 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 83 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 84 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 85 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 86 MEA Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 87 MEA Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 88 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 89 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 90 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 91 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Danaher Corporation: Product Benchmarking
Table 93 Danaher Corporation: Strategic Outlook
Table 94 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 PerkinElmer Inc.: Product Benchmarking
Table 96 PerkinElmer Inc.: Strategic Outlook
Table 97 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott: Product Benchmarking
Table 99 Abbott: Strategic Outlook
Table 100 BioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 BioMérieux SA: Product Benchmarking
Table 102 BioMérieux SA: Strategic Outlook
Table 103 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 105 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 106 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Becton, Dickinson and Company: Product Benchmarking
Table 108 Becton, Dickinson and Company: Strategic Outlook
Table 109 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Bio-Rad Laboratories: Product Benchmarking
Table 111 Bio-Rad Laboratories: Strategic Outlook
Table 112 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Siemens Healthineers: Product Benchmarking
Table 114 Siemens Healthineers: Strategic Outlook
Table 115 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Thermo Fisher Scientific: Product Benchmarking
Table 117 Thermo Fisher Scientific: Strategic Outlook
Table 118 Quidel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Quidel Corporation: Product Benchmarking
Table 120 Quidel Corporation: Strategic Outlook

図の一覧
Figure 1 Global Clinical Trials Supply and Logistics Market Segmentation
Figure 2 Infectious Disease Diagnostics Market by Product: Market Attractiveness Index
Figure 3 Infectious Disease Diagnostics Market Attractiveness Index by Region
Figure 4 Infectious Disease Diagnostics : Market Dynamics
Figure 5 Global COVID Impact Analysis: Infectious Disease Diagnostics Market Recovery Scenarios
Figure 6 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
2027
Figure 7 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 8 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 9 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 10 Infectious Disease Diagnostics Market: Porter’s Five Forces Analysis
Figure 11 Infectious Disease Diagnostics Market: PEST Analysis
Figure 12 Infectious Disease Diagnostics Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR %)
Figure 13 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 14 Infectious Disease Diagnostics Market Share Forecast by Product, 2022, 2027, 2032 (%)
f research laboratories and increased funding from public and private organizations for the development of diagnostic instruments in the pharmaceutical and biotechnology industry, the instruments segment is anticipated to experience significant growth during the forecast period.
Figure 15 Instrument Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 Instrument Market Share Forecast by Region, 2022 & 2032 (%)
Figure 17 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Reagents, Kits, and Consumables Market Share Forecast by Region, 2022 & 2032 (%)
Figure 19 Software & Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 20 Software & Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 21 Infectious Disease Diagnostics Market Forecast by Type of Testing 2022, 2027, 2032 (Revenue, CAGR %)
Figure 22 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 23 Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022, 2027, 2032 (%)
Figure 24 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Laboratory Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 POC Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 POC Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Infectious Disease Diagnostics Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR%)
Figure 29 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 30 Infectious Disease Diagnostics Market Share Forecast by Technology, 2022, 2027, 2032 (%)
Figure 31 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Immunodiagnostics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 33 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 Polymerase Chain Reaction (PCR) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 35 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 DNA Sequencing and Next-Generation Sequencing (NGS) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Clinical Microbiology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Other technologies Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Other technologies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Infectious Disease Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 42 Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 43 Infectious Disease Diagnostics Market Share Forecast by Application, 2022, 2027, 2032 (%)
Figure 44 COVID-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 45 COVID-19 Market Share Forecast by Region, 2022 & 2032 (%)
Figure 46 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 47 Human Immunodeficiency Virus (HIV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 48 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ million)
Figure 49 Healthcare-Associated Infections (HAIs) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 50 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Hepatitis Market Share Forecast by Region, 2022 & 2032 (%)
Figure 52 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Human Papillomavirus (HPV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 54 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ million)
Figure 55 Tuberculosis (TB) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 57 Influenza Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 59 Other Infectious Diseases Market Share Forecast by Region, 2022 & 2032 (%)
Figure 60 Infectious Disease Diagnostics Market Forecast by End User 2022, 2027, 2032 (Revenue, CAGR%)
Figure 61 Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ million)
Figure 62 Infectious Disease Diagnostics Market Share Forecast by End User, 2022, 2027, 2032 (%)
Figure 63 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 64 Diagnostic Laboratories Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million)
Figure 66 Hospitals & Clinics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Research Institutes Market Forecast by Region, 2022-2032 (US$ million)
Figure 68 Research Institutes Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 70 Home Care Settings Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Other End Users Market Forecast by Region, 2022-2032 (US$ million)
Figure 72 Other End Users Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 Infectious Disease Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 74 Infectious Disease Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Figure 76 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 77 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 78 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 79 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 80 North America Infectious Disease Diagnostics Market Attractiveness Index
Figure 81 North America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 82 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 83 North America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 84 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 85 North America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 86 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 87 North America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 88 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 89 North America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 90 North America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 91 North America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 92 North America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 93 North America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 94 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 95 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 96 Europe Infectious Disease Diagnostics Market Attractiveness Index
Figure 97 Europe Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 98 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 99 Europe Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 100 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 101 Europe Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 102 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 103 Europe Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 104 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 105 Europe Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 106 Europe Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 107 Europe Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 108 Europe Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 109 Europe Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 110 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 111 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 112 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 113 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 114 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 115 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
Figure 118 Asia Pacific Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 120 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 122 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 123 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 124 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 125 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 126 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 127 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 128 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 129 Asia Pacific Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 130 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 131 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 132 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 133 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 134 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 135 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 136 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 137 Latin America Infectious Disease Diagnostics Market Attractiveness Index
Figure 138 Latin America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 139 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 140 Latin America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 141 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 142 Latin America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 143 Latin America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 144 Latin America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 145 Latin America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 146 Latin America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 147 Latin America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 148 Latin America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 149 Latin America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 150 Latin America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 151 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 152 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 153 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 154 MEA Infectious Disease Diagnostics Market Attractiveness Index
Figure 155 MEA Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 156 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 157 MEA
Figure 158 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 159 MEA Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 160 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 161 MEA Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 162 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 163 MEA Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 164 MEA Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 165 MEA Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 166 MEA Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 167 MEA Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 168 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 169 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 170 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 171 Infectious Disease Diagnostics Market: Company Share/Ranking, 2021
Figure 172 Danaher Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 173 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Danaher Corporation: Regional Market Shares, 2021
Figure 175 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 177 PerkinElmer Inc.: Regional Market Shares, 2021
Figure 178 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 180 Abbott: Regional Market Shares, 2021
Figure 181 BioMérieux SA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 BioMérieux SA: R&D, 2017-2021 (US$ million, AGR%)
Figure 183 BioMérieux SA: Regional Market Shares, 2021
Figure 184 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2021
Figure 187 Becton, Dickinson and Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Becton, Dickinson and Company: R&D, 2017-2021 (US$ million, AGR%)
Figure 189 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 190 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Bio-Rad Laboratories: Regional Market Shares, 2021
Figure 193 Siemens Healthineers: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 194 Siemens Healthineers: R&D, 2017-2021 (US$ million, AGR%)
Figure 195 Siemens Healthineers: Regional Market Shares, 2021
Figure 196 Thermo Fisher Scientific: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Thermo Fisher Scientific: R&D, 2017-2021 (US$ million, AGR%)
Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 199 Quidel Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Quidel Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 201 Quidel Corporation: Regional Market Shares, 2021

ページTOPに戻る

Table of Contents

Summary

Report Details

The Infectious Disease Diagnostics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Prevalence of Infectious Diseases, And Shift in Focus from Centralized Laboratories to Decentralized POC Testing Are Driving the Market Growth
Growing prevalence of infectious diseases is anticipated to drive the growth of the infectious disease diagnostics market over the forecast period. For instance, on February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases of coronavirus disease 2019 in locations outside mainland China and the number of associated deaths was 2,462.

According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), 37.7 million individuals were HIV positive in 2020, out of which 36 million were adults and 1.7 million were children between the ages of 0 and 14. Furthermore, more than half (53%) were females. 1.5 million new HIV cases were recorded in 2020 worldwide. Further, Hepatitis is a viral infection that results in liver inflammation. Hepatitis viruses come in five primary strains: A, B, C, D, and E. As per the World Health Organization (WHO), about 58 million individuals worldwide have chronic hepatitis C virus infection, and 1.5 million new infections occur each year.

According to WHO, After COVID-19, tuberculosis (TB) is the second most common infectious disease in the world and the thirteenth leading cause of death overall. As per WHO, 1.5 million deaths were caused due to TB in 2020 (including 214,000 people affected by HIV). WHO anticipated that 10 million individuals, including 1.1 million children, 3.3 million women, and 5.6 million men, would be affected by TB worldwide in 2020. All countries and age ranges are affected by TB. In addition, 30 countries with heavy TB burdens accounted for 86% of new TB cases in 2020. Two-thirds of the total is made up of eight countries, with India topping the list, then China, the Philippines, Nigeria, Pakistan, Indonesia, Bangladesh, and South Africa.

Moreover, the growing prevalence of healthcare-acquired infections (HAIs) globally. For instance, according to the Centers for Disease Control (CDC), HAIs alone in American hospitals are considered to be responsible for 1.7 million infections and 99,000 associated deaths per year. Of these infections, urinary tract infections make up 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%).

Growing prevalence of infectious diseases in developed and emerging nations will positively impact the growth of the infectious disease diagnostics market. The diagnosis and management of these diseases are key responsible factors for the rising number of prescriptions for diagnostic tests for infectious diseases. Large-scale population-based diagnostic testing is required for the prevention and control measures of COVID-19.

What Questions Should You Ask before Buying a Market Research Report?
• How is the infectious disease diagnostics market evolving?
• What is driving and restraining the infectious disease diagnostics market?
• How will each infectious disease diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each infectious disease diagnostics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading infectious disease diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the infectious disease diagnostics research projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of infectious disease diagnostics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the infectious disease diagnostics market?
• Where is the infectious disease diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Infectious Disease Diagnostics Market today, and over the next 10 years:
• Our Visiongain’s 32-page report provides 120 tables and 201 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Infectious Disease Diagnostics Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising infectious disease diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product
• Instrument
• Reagents, Kits, and Consumables
• Software & Services

Type of Testing
• Laboratory Testing
• POC Testing

Technology
• Immunodiagnostics
• Polymerase Chain Reaction (PCR)
– Real-time PCR/qPCR
– Reverse Transcriptase PCR (RT-PCR)
– Multiplex PCR
– Others
• DNA Sequencing and Next-Generation Sequencing (NGS)
• Clinical Microbiology
• Other technologies

Application
• COVID-19
• Human Immunodeficiency Virus (HIV)
• Healthcare-Associated Infections (HAIs)
• Hepatitis
• Human Papillomavirus (HPV)
• Tuberculosis (TB)
• Influenza
• Other Infectious Diseases

Application
• Diagnostic Laboratories
• Hospitals & Clinics
• Research Institutes
• Home Care Settings
• Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 19 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott
• Alere Inc.
• BioMérieux SA
• Becton, Dickinson and Company
• Cepheid, Inc.
• Co-Diagnostics
• Chembio Diagnostic Systems
• Danaher Corporation
• DiaSorin S.p.A.
• ELITechGroup
• Epitope Diagnostics
• F. Hoffmann-La Roche
• Hologic, Inc.
• Grifols S.A.
• Genetic Signatures Ltd.
• InBios International
• Meridian Bioscience
• Ortho Clinical Diagnostics Holdings plc
• OraSure Technologies
• PerkinElmer Inc.
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific
• Trinity Biotech Plc.
• Trivitron Healthcare
• Uniogen Oy
• Vela Diagnostics
• Meril Life Sciences Pvt. Ltd
• Quidel Corporation.

Overall world revenue for Infectious Disease Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$ 29,940.3 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Infectious Disease Diagnostics Market, 2022 to 2032 report help you?
In summary, our 320+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Infectious Disease Diagnostics Market, 2022 to 2032 Market, with forecasts for type and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 19 key national markets – See forecasts for the Infectious Disease Diagnostics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Infectious Disease Diagnostics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Infectious Disease Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Infectious Disease Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Prevalence of Infectious Diseases
3.2.1.2 Shift in Focus from Centralized Laboratories to Decentralized POC Testing
3.2.1.3 Increase in Funding from Private & Government Organizations for Diagnostic Service Center
3.2.2 Market Restraining Factors
3.2.2.1 Unfavourable Reimbursement Scenario
3.2.2.2 Shortage of Skilled Professionals
3.2.3 Market Opportunities
3.2.3.1 Growing opportunities in growing economies
3.2.3.2 Introduction of cost-effective and reliable test kits
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Infectious Disease Diagnostics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment Growth Prospects
4.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
4.4 Instrument
4.4.1 Market Size by Region, 2022-2032 (US$ Million)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Reagents, Kits, and Consumables
4.5.1 Market Size by Region, 2022-2032 (US$ Million)
4.5.2 Market Share by Region, 2022 & 2032 (%)
4.6 Software & Services
4.6.1 Market Size by Region, 2022-2032 (US$ Million)
4.6.2 Market Share by Region, 2022 & 2032 (%)

5 Infectious Disease Diagnostics Market Analysis by Type of Testing
5.1 Key Findings
5.2 Type of Testing Segment Growth Prospects
5.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
5.4 Laboratory Testing
5.4.1 Market Size by Region, 2022-2032 (US$ Million)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 POC Testing
5.5.1 Market Size by Region, 2022-2032 (US$ Million)
5.5.2 Market Share by Region, 2022 & 2032 (%)

6 Infectious Disease Diagnostics Market Analysis by Technology
6.1 Key Findings
6.2 Technology Segment Growth Prospects
6.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
6.4 Immunodiagnostics
6.4.1 Market Size by Region, 2022-2032 (US$ Million)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.6 Polymerase Chain Reaction (PCR)
6.6.1 Market Size by Region, 2022-2032 (US$ Million)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 DNA Sequencing and Next-Generation Sequencing (NGS)
6.7.1 Market Size by Region, 2022-2032 (US$ Million)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Clinical Microbiology
6.8.1 Market Size by Region, 2022-2032 (US$ Million)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Other technologies
6.9.1 Market Size by Region, 2022-2032 (US$ Million)
6.9.2 Market Share by Region, 2022 & 2032 (%)

7 Infectious Disease Diagnostics Market Analysis by Application
7.1 Key Findings
7.2 Application Segment Growth Prospects
7.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
7.4 COVID-19
7.4.1 Market Size by Region, 2022-2032 (US$ Million)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Human Immunodeficiency Virus (HIV)
7.5.1 Market Size by Region, 2022-2032 (US$ Million)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Healthcare-Associated Infections (HAIs)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Hepatitis
7.7.1 Market Size by Region, 2022-2032 (US$ Million)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Human Papillomavirus (HPV)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Tuberculosis (TB)
7.9.1 Market Size by Region, 2022-2032 (US$ Million)
7.9.2 Market Share by Region, 2022 & 2032 (%)
7.10 Influenza
7.10.1 Market Size by Region, 2022-2032 (US$ Million)
7.10.2 Market Share by Region, 2022 & 2032 (%)
7.11 Other Infectious Diseases
7.11.1 Market Size by Region, 2022-2032 (US$ Million)
7.11.2 Market Share by Region, 2022 & 2032 (%)

8 Infectious Disease Diagnostics Market Analysis by End User
8.1 Key Findings
8.2 End User Segment Growth Prospects
8.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
8.4 Diagnostic Laboratories
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Hospitals & Clinics
8.5.1 Market Size by Region, 2022-2032 (US$ Million)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Research Institutes
8.6.1 Market Size by Region, 2022-2032 (US$ Million)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Home Care Settings
8.7.1 Market Size by Region, 2022-2032 (US$ Million)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Other End Users
8.8.1 Market Size by Region, 2022-2032 (US$ Million)
8.8.2 Market Share by Region, 2022 & 2032 (%)

9 Infectious Disease Diagnostics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

10 North America Infectious Disease Diagnostics Market Analysis
10.1 Key Findings
10.2 North America Infectious Disease Diagnostics Market Attractiveness Index
10.3 North America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
10.4 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
10.5 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
10.6 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
10.7 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
10.8 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
10.9 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by End users
10.10 U.S. Infectious Disease Diagnostics Market Analysis
10.11 Canada Infectious Disease Diagnostics Market Analysis

11 Europe Infectious Disease Diagnostics Market Analysis
11.1 Key Findings
11.2 Europe Infectious Disease Diagnostics Market Attractiveness Index
11.3 Europe Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
11.4 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
11.5 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
11.6 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
11.7 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
11.8 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
11.9 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
11.10 Germany Infectious Disease Diagnostics Market Analysis
11.11 UK Infectious Disease Diagnostics Market Analysis
11.12 France Infectious Disease Diagnostics Market Analysis
11.12 Italy Infectious Disease Diagnostics Market Analysis
11.13 Spain Infectious Disease Diagnostics Market Analysis
11.14 Russia Infectious Disease Diagnostics Market Analysis
11.15 Rest of Europe Infectious Disease Diagnostics Market Analysis

12 Asia Pacific Infectious Disease Diagnostics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
12.3 Asia Pacific Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
12.4 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
12.7 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
12.8 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
12.9 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
12.10 Japan Infectious Disease Diagnostics Market Analysis
12.11 China Infectious Disease Diagnostics Market Analysis
12.12 India Infectious Disease Diagnostics Market Analysis
12.13 Australia Infectious Disease Diagnostics Market Analysis
12.14 South Korea Infectious Disease Diagnostics Market Analysis
12.15 Rest of Asia Pacific Infectious Disease Diagnostics Market Analysis

13 Latin America Infectious Disease Diagnostics Market Analysis
13.1 Key Findings
13.2 Latin America Infectious Disease Diagnostics Market Attractiveness Index
13.3 Latin America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
13.4 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
13.5 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
13.6 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
13.7 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
13.8 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
13.9 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
13.10 Brazil Infectious Disease Diagnostics Market Analysis
13.11 Mexico Infectious Disease Diagnostics Market Analysis
13.12 Rest of Latin America Infectious Disease Diagnostics Market Analysis

14 MEA Infectious Disease Diagnostics Market Analysis
14.1 Key Findings
14.2 MEA Infectious Disease Diagnostics Market Attractiveness Index
14.3 MEA Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
14.4 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
14.5 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
14.6 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
14.7 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
14.8 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
14.9 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
14.10 GCC Infectious Disease Diagnostics Market Analysis
14.11 South Africa Infectious Disease Diagnostics Market Analysis
14.12 Rest of MEA Infectious Disease Diagnostics Market Analysis

15 Company Profiles
15.1 Competitive Landscape, 2021
15.2 Danaher Corporation
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2017-2021
15.2.3.2 R&D, 2017-2021
15.2.3.3 Regional Market Shares, 2021
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 PerkinElmer Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 R&D, 2017-2021
15.3.3.3 Regional Market Shares, 2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Abbott
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 R&D, 2017-2021
15.4.3.3 Regional Market Shares, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 BioMérieux SA
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 R&D, 2017-2021
15.5.3.3 Regional Market Shares, 2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 F. Hoffmann-La Roche Ltd
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 R&D, 2017-2021
15.6.3.3 Regional Market Shares, 2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Becton, Dickinson and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 R&D, 2017-2021
15.7.3.3 Regional Market Shares, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bio-Rad Laboratories
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 R&D, 2017-2021
15.8.3.3 Regional Market Shares, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Siemens Healthineers
15.9.1 Company Snapshot
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.3.3 Regional Market Shares, 2021
15.9.4 Product Benchmarking
15.9.4 Strategic Outlook
15.10 Thermo Fisher Scientific
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.3.3 Regional Market Shares, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Quidel Corporation
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.3.3 Regional Market Shares, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Infectious Disease Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 3 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 7 Instrument Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 9 Software & Services Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 10 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 11 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 12 POC Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 14 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 15 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 16 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 17 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 18 Immunodiagnostics market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 20 COVID-19 Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 21 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 23 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 24 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 25 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 26 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 27 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 28 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 29 Global Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 30 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 31 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 32 Research Institutes Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 33 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 34 Other End Users Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 35 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%))
Table 36 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 37 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 38 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 39 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 40 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 41 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 42 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 43 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 44 North America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 45 North America Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 46 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 47 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 48 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 49 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 50 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 51 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 52 Europe Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 53 Europe Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 54 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 55 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 56 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 57 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 58 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 59 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 60 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 61 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 62 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 63 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 64 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 65 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 66 Asia Pacific Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 67 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 68 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 69 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 70 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 71 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 73 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 74 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 75 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 76 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 77 Latin America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 78 Latin America Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 79 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 80 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 81 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 82 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 83 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 84 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 85 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 86 MEA Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 87 MEA Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 88 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 89 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 90 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 91 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Danaher Corporation: Product Benchmarking
Table 93 Danaher Corporation: Strategic Outlook
Table 94 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 PerkinElmer Inc.: Product Benchmarking
Table 96 PerkinElmer Inc.: Strategic Outlook
Table 97 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott: Product Benchmarking
Table 99 Abbott: Strategic Outlook
Table 100 BioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 BioMérieux SA: Product Benchmarking
Table 102 BioMérieux SA: Strategic Outlook
Table 103 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 105 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 106 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Becton, Dickinson and Company: Product Benchmarking
Table 108 Becton, Dickinson and Company: Strategic Outlook
Table 109 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Bio-Rad Laboratories: Product Benchmarking
Table 111 Bio-Rad Laboratories: Strategic Outlook
Table 112 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Siemens Healthineers: Product Benchmarking
Table 114 Siemens Healthineers: Strategic Outlook
Table 115 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Thermo Fisher Scientific: Product Benchmarking
Table 117 Thermo Fisher Scientific: Strategic Outlook
Table 118 Quidel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Quidel Corporation: Product Benchmarking
Table 120 Quidel Corporation: Strategic Outlook

List of Figures
Figure 1 Global Clinical Trials Supply and Logistics Market Segmentation
Figure 2 Infectious Disease Diagnostics Market by Product: Market Attractiveness Index
Figure 3 Infectious Disease Diagnostics Market Attractiveness Index by Region
Figure 4 Infectious Disease Diagnostics : Market Dynamics
Figure 5 Global COVID Impact Analysis: Infectious Disease Diagnostics Market Recovery Scenarios
Figure 6 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
2027
Figure 7 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 8 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 9 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 10 Infectious Disease Diagnostics Market: Porter’s Five Forces Analysis
Figure 11 Infectious Disease Diagnostics Market: PEST Analysis
Figure 12 Infectious Disease Diagnostics Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR %)
Figure 13 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 14 Infectious Disease Diagnostics Market Share Forecast by Product, 2022, 2027, 2032 (%)
f research laboratories and increased funding from public and private organizations for the development of diagnostic instruments in the pharmaceutical and biotechnology industry, the instruments segment is anticipated to experience significant growth during the forecast period.
Figure 15 Instrument Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 Instrument Market Share Forecast by Region, 2022 & 2032 (%)
Figure 17 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Reagents, Kits, and Consumables Market Share Forecast by Region, 2022 & 2032 (%)
Figure 19 Software & Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 20 Software & Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 21 Infectious Disease Diagnostics Market Forecast by Type of Testing 2022, 2027, 2032 (Revenue, CAGR %)
Figure 22 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 23 Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022, 2027, 2032 (%)
Figure 24 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Laboratory Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 POC Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 POC Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Infectious Disease Diagnostics Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR%)
Figure 29 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 30 Infectious Disease Diagnostics Market Share Forecast by Technology, 2022, 2027, 2032 (%)
Figure 31 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Immunodiagnostics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 33 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 Polymerase Chain Reaction (PCR) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 35 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 DNA Sequencing and Next-Generation Sequencing (NGS) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Clinical Microbiology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Other technologies Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Other technologies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Infectious Disease Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 42 Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 43 Infectious Disease Diagnostics Market Share Forecast by Application, 2022, 2027, 2032 (%)
Figure 44 COVID-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 45 COVID-19 Market Share Forecast by Region, 2022 & 2032 (%)
Figure 46 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 47 Human Immunodeficiency Virus (HIV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 48 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ million)
Figure 49 Healthcare-Associated Infections (HAIs) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 50 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Hepatitis Market Share Forecast by Region, 2022 & 2032 (%)
Figure 52 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Human Papillomavirus (HPV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 54 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ million)
Figure 55 Tuberculosis (TB) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 57 Influenza Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 59 Other Infectious Diseases Market Share Forecast by Region, 2022 & 2032 (%)
Figure 60 Infectious Disease Diagnostics Market Forecast by End User 2022, 2027, 2032 (Revenue, CAGR%)
Figure 61 Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ million)
Figure 62 Infectious Disease Diagnostics Market Share Forecast by End User, 2022, 2027, 2032 (%)
Figure 63 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 64 Diagnostic Laboratories Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million)
Figure 66 Hospitals & Clinics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Research Institutes Market Forecast by Region, 2022-2032 (US$ million)
Figure 68 Research Institutes Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 70 Home Care Settings Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Other End Users Market Forecast by Region, 2022-2032 (US$ million)
Figure 72 Other End Users Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 Infectious Disease Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 74 Infectious Disease Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Figure 76 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 77 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 78 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 79 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 80 North America Infectious Disease Diagnostics Market Attractiveness Index
Figure 81 North America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 82 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 83 North America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 84 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 85 North America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 86 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 87 North America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 88 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 89 North America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 90 North America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 91 North America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 92 North America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 93 North America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 94 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 95 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 96 Europe Infectious Disease Diagnostics Market Attractiveness Index
Figure 97 Europe Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 98 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 99 Europe Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 100 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 101 Europe Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 102 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 103 Europe Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 104 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 105 Europe Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 106 Europe Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 107 Europe Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 108 Europe Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 109 Europe Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 110 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 111 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 112 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 113 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 114 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 115 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
Figure 118 Asia Pacific Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 120 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 122 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 123 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 124 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 125 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 126 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 127 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 128 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 129 Asia Pacific Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 130 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 131 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 132 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 133 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 134 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 135 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 136 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 137 Latin America Infectious Disease Diagnostics Market Attractiveness Index
Figure 138 Latin America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 139 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 140 Latin America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 141 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 142 Latin America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 143 Latin America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 144 Latin America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 145 Latin America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 146 Latin America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 147 Latin America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 148 Latin America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 149 Latin America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 150 Latin America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 151 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 152 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 153 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 154 MEA Infectious Disease Diagnostics Market Attractiveness Index
Figure 155 MEA Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 156 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 157 MEA
Figure 158 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 159 MEA Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 160 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 161 MEA Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 162 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 163 MEA Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 164 MEA Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 165 MEA Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 166 MEA Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 167 MEA Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 168 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 169 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 170 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 171 Infectious Disease Diagnostics Market: Company Share/Ranking, 2021
Figure 172 Danaher Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 173 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Danaher Corporation: Regional Market Shares, 2021
Figure 175 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 177 PerkinElmer Inc.: Regional Market Shares, 2021
Figure 178 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 180 Abbott: Regional Market Shares, 2021
Figure 181 BioMérieux SA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 BioMérieux SA: R&D, 2017-2021 (US$ million, AGR%)
Figure 183 BioMérieux SA: Regional Market Shares, 2021
Figure 184 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2021
Figure 187 Becton, Dickinson and Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Becton, Dickinson and Company: R&D, 2017-2021 (US$ million, AGR%)
Figure 189 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 190 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Bio-Rad Laboratories: Regional Market Shares, 2021
Figure 193 Siemens Healthineers: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 194 Siemens Healthineers: R&D, 2017-2021 (US$ million, AGR%)
Figure 195 Siemens Healthineers: Regional Market Shares, 2021
Figure 196 Thermo Fisher Scientific: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Thermo Fisher Scientific: R&D, 2017-2021 (US$ million, AGR%)
Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 199 Quidel Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Quidel Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 201 Quidel Corporation: Regional Market Shares, 2021

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（infectious disease）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

感染症診断薬市場レポート：2022-2032

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（診断薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（infectious disease）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?